My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 356

    1.

    Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease.

    Gnjec A, D'Costa KJ, Laws SM, Hedley R, Balakrishnan K, Taddei K, Martins G, Paton A, Verdile G, Gandy SE, Broe GA, Brooks WS, Bennett H, Piguet O, Price P, Miklossy J, Hallmayer J, McGeer PL, Martins RN.

    J Neuroinflammation. 2008 Aug 20;5:36.PMID: 18715507 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    BAT1 promoter polymorphism is associated with rheumatoid arthritis susceptibility.

    Quiñones-Lombraña A, Lopez-Soto A, Ballina-Garcia FJ, Alperi-López M, Queiro-Silva R, Lopez-Vazquez A, Lopez-Larrea C, Gonzalez S.

    J Rheumatol. 2008 May;35(5):741-4. Epub 2008 Mar 15.PMID: 18381799 [PubMed - indexed for MEDLINE]Related articles

    3.

    Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.

    Kuwano R, Miyashita A, Arai H, Asada T, Imagawa M, Shoji M, Higuchi S, Urakami K, Kakita A, Takahashi H, Tsukie T, Toyabe S, Akazawa K, Kanazawa I, Ihara Y; Japanese Genetic Study Consortium for Alzeheimer's Disease.

    Hum Mol Genet. 2006 Jul 1;15(13):2170-82. Epub 2006 Jun 1.PMID: 16740596 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Alleles of the proximal promoter of BAT1, a putative anti-inflammatory gene adjacent to the TNF cluster, reduce transcription on a disease-associated MHC haplotype.

    Wong AM, Allcock RJ, Cheong KY, Christiansen FT, Price P.

    Genes Cells. 2003 Apr;8(4):403-12.PMID: 12653967 [PubMed - indexed for MEDLINE]Related articles

    5.

    Polymorphisms at positions -22 and -348 in the promoter of the BAT1 gene affect transcription and the binding of nuclear factors.

    Price P, Wong AM, Williamson D, Voon D, Baltic S, Allcock RJ, Boodhoo A, Christiansen FT.

    Hum Mol Genet. 2004 May 1;13(9):967-74. Epub 2004 Mar 17.PMID: 15028669 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Tumor necrosis factor alpha and interleukin 10 promoter region polymorphisms and risk of late-onset Alzheimer disease.

    Ramos EM, Lin MT, Larson EB, Maezawa I, Tseng LH, Edwards KL, Schellenberg GD, Hansen JA, Kukull WA, Jin LW.

    Arch Neurol. 2006 Aug;63(8):1165-9.PMID: 16908746 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation.

    Licastro F, Porcellini E, Caruso C, Lio D, Corder EH.

    Neurobiol Aging. 2007 Nov;28(11):1637-43. Epub 2006 Aug 22.PMID: 16930778 [PubMed - indexed for MEDLINE]Related articles

    8.

    Association between the macrophage inflammatory protein-l alpha gene polymorphism and Alzheimer's disease in the Chinese population.

    Li K, Dai D, Yao L, Gu X, Luan K, Tian W, Zhao Y, Wang B.

    Neurosci Lett. 2008 Mar 12;433(2):125-8. Epub 2008 Jan 10.PMID: 18242850 [PubMed - indexed for MEDLINE]Related articles

    9.

    TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease.

    Culpan D, Cram D, Chalmers K, Cornish A, Palmer L, Palmer J, Hughes A, Passmore P, Craigs D, Wilcock GK, Kehoe PG, Love S.

    Neurobiol Aging. 2009 Jul;30(7):1052-60. Epub 2007 Dec 11.PMID: 18069092 [PubMed - indexed for MEDLINE]Related articles

    10.

    Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E.

    Laws SM, Hone E, Taddei K, Harper C, Dean B, McClean C, Masters C, Lautenschlager N, Gandy SE, Martins RN.

    Mol Psychiatry. 2002;7(8):886-90.PMID: 12232782 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease.

    Chapuis J, Hot D, Hansmannel F, Kerdraon O, Ferreira S, Hubans C, Maurage CA, Huot L, Bensemain F, Laumet G, Ayral AM, Fievet N, Hauw JJ, DeKosky ST, Lemoine Y, Iwatsubo T, Wavrant-Devrièze F, Dartigues JF, Tzourio C, Buée L, Pasquier F, Berr C, Mann D, Lendon C, Alpérovitch A, Kamboh MI, Amouyel P, Lambert JC.

    Mol Psychiatry. 2009 Nov;14(11):1004-16. Epub 2009 Feb 10.PMID: 19204726 [PubMed - indexed for MEDLINE]Related articles

    12.

    Tumour necrosis factor-alpha gene polymorphisms and Alzheimer's disease.

    Culpan D, MacGowan SH, Ford JM, Nicoll JA, Griffin WS, Dewar D, Cairns NJ, Hughes A, Kehoe PG, Wilcock GK.

    Neurosci Lett. 2003 Oct 16;350(1):61-5.PMID: 12962917 [PubMed - indexed for MEDLINE]Related articles

    13.

    ApoE -491A/T promoter polymorphism is not an independent risk factor, but associated with the epsilon4 allele in Hungarian Alzheimer's dementia population.

    Juhász A, Palotás A, Janka Z, Rimanóczy A, Palotás M, Bódi N, Boda K, Zana M, Vincze G, Kálmán J.

    Neurochem Res. 2005 May;30(5):591-6.PMID: 16176061 [PubMed - indexed for MEDLINE]Related articles

    14.

    Protein and gene expression of tumour necrosis factor receptors I and II and their promoter gene polymorphisms in Alzheimer's disease.

    Culpan D, Cornish A, Love S, Kehoe PG, Wilcock GK.

    Exp Gerontol. 2007 Jun;42(6):538-44. Epub 2007 Jan 30.PMID: 17267158 [PubMed - indexed for MEDLINE]Related articles

    15.

    APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.

    Sando SB, Melquist S, Cannon A, Hutton ML, Sletvold O, Saltvedt I, White LR, Lydersen S, Aasly JO.

    BMC Neurol. 2008 Apr 16;8:9.PMID: 18416843 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The combinations of TNFalpha-308 and IL-6 -174 or IL-10 -1082 genes polymorphisms suggest an association with susceptibility to sporadic late-onset Alzheimer's disease.

    Vural P, Değirmencioğlu S, Parildar-Karpuzoğlu H, Doğru-Abbasoğlu S, Hanagasi HA, Karadağ B, Gürvit H, Emre M, Uysal M.

    Acta Neurol Scand. 2009 Dec;120(6):396-401. Epub 2009 Sep 10.PMID: 19744138 [PubMed - indexed for MEDLINE]Related articles

    17.

    Association between tumor necrosis factor-alpha promoter polymorphism and Alzheimer's disease.

    Ma SL, Tang NL, Lam LC, Chiu HF.

    Neurology. 2004 Jan 27;62(2):307-9.PMID: 14745077 [PubMed - indexed for MEDLINE]Related articles

    18.

    Association of IL10 promoter polymorphism in Italian Alzheimer's disease.

    Bagnoli S, Cellini E, Tedde A, Nacmias B, Piacentini S, Bessi V, Bracco L, Sorbi S.

    Neurosci Lett. 2007 May 18;418(3):262-5. Epub 2007 Mar 19.PMID: 17420099 [PubMed - indexed for MEDLINE]Related articles

    19.

    Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles.

    Bennett DA, De Jager PL, Leurgans SE, Schneider JA.

    Neurology. 2009 Apr 28;72(17):1495-503.PMID: 19398704 [PubMed - indexed for MEDLINE]Related articles

    20.

    TP73 allelic expression in human brain and allele frequencies in Alzheimer's disease.

    Li Q, Athan ES, Wei M, Yuan E, Rice SL, Vonsattel JP, Mayeux RP, Tycko B.

    BMC Med Genet. 2004 Jun 2;5:14.PMID: 15175114 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk